“Patients who received the medicine exhibited significant enhancement” | ynet

Zyon Ayni - ynet

Dr. Eynat Finkelshtein, Chief Scientific Officer at Code Pharma, featured on ynet TV to discuss Codivir: “When the Covid-19 appeared, we wanted to explore whether our treatment was also effective against Covid.”

“In a matter of hours or days, the patients who received the medicine exhibited significant enhancement. Based on these findings, we already have emergency permits to use the medicine in Brazil and Africa”. Dr. Finkelshtein remarked: “Other countries want to join.”

Zyon Ayni established Code Pharma, a multinational corporation with trained and experienced employees for viral infections, HIV, and cancer research.

Facebook
Twitter
LinkedIn
Pinterest
Accessibility